The European Journal of Cancer (abbreviated as EJC or Eur. J. Cancer) is a peer-reviewed medical journal devoted to cancer research on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), and on cancer epidemiology and prevention. It is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA). The editor-in-chief is Alexander M. M. Eggermont. In Clarivate's 2021 Journal Citation Reports indexed by Web of Science, the European Journal of Cancer received an impact factor of 10.002, ranking it 21st journal out of 220 journals in the category cancer research and 26th journal out of 369 journals in the category oncology in the Scimago Journal Ranking. Source: Wikipedia (en)
Editions published in European Journal of Cancer 200
-
Squamous cell carcinoma of the pancreas: A systematic review and pooled survival analysis
-
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
-
Primary, secondary and tertiary prevention of human papillomavirus-driven head and neck cancers.
-
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
-
Phase-II trials in osteosarcoma recurrences: A systematic review of past experience
-
Anthropometrics at birth and risk of a primary central nervous system tumour: A systematic review and meta-analysis.
-
Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer
-
Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials
-
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
-
A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients
-
Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
-
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumours.
-
The use of EORTC measures in daily clinical practice-A synopsis of a newly developed manual
-
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology
-
Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs
-
Biology and treatment of renal tumours in childhood
-
Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain
-
Rationale for anti-GITR cancer immunotherapy
-
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
-
The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis.
-
Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis
-
Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence.
-
Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives
-
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review
-
Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
-
Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register
-
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutati
-
Uveal Melanoma UK National Guidelines
-
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer
-
Are we ready to predict late effects? A systematic review of clinically useful prediction models
-
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel
-
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
件名 - wd:Q332260